Latest Research on Migraine Treatments - WebMD
Feb 12, 2023 · These advances include new drugs and new delivery systems (nasal sprays, needle injections) that may work better and with fewer side effects than older migraine medications.
The American Headache Society Consensus Statement: Update …
Jun 23, 2021 · The development and introduction of new medications and devices has led to important advances in the acute and preventive treatment of migraine. As a result, the appropriate and cost-effective integration of these new treatments remains a high priority for …
New Treatments for Migraine - American Migraine Foundation
Oct 11, 2021 · Check out our recent webinar with Drs. Jessica Aliani and Stewart Tepper, where we review new migraine treatments, including anti-CGRPs, DHE, and more.
FDA approves new nasal spray to treat migraine headaches in ... - CNN
Mar 10, 2023 · The US Food and Drug Administration approved a new nasal spray as a rapid treatment for migraine pain in adults.
An Expert Talks About New Research on Migraine Treatments - Healthline
May 10, 2024 · Neurologist Dr. Susan Lee discusses newer migraine treatments, such as CGRP antagonists, lasmiditan, and neuromodulating devices.
What are the new drugs for the treatment of migraines?
Apr 27, 2023 · The newest oral drugs for the acute treatment of migraine are Nurtec ODT and Ubrelvy , both orally-administered calcitonin gene-related peptide (CGRP) receptor antagonists (gepants). Another new drug for the acute treatment of migraine is Reyvow , the first serotonin (5-HT) 1F receptor agonist.
These Drugs Are the New First Line of Defense Against Migraine
Apr 3, 2024 · Currently, there are four CGRP-targeted mAbs and two gepants approved by the Food and Drug Administration (FDA) for the preventive treatment of migraine. These medications work by stopping CGRP’s action, whether by blocking the receptor site or …
Migraine treatments: What are the latest advances?
Apr 12, 2024 · This knowledge has led to a new class of medications called anti-CGRP (calcitonin gene-related peptide) drugs, which can be used acutely to treat a migraine attack once it begins, or to prevent migraine attacks from occurring. Multiple anti-CGRP drugs are now on the market.
An update on migraine: Current and new treatment options
May 1, 2024 · With the recent advances in new drugs and device technology for the treatment of migraine, the American Headache Society has released a consensus statement on both preventive and acute strategies for clinical practice.
Advances in migraine treatment - Mayo Clinic Press
Jan 19, 2024 · Ubrogepant (Ubrelvy) and rimegepant (Nurtec ODT) are new CGRP receptor antagonists for as-needed treatment of migraine that do not narrow blood vessels. These oral medications block the CGRP receptor to hopefully stop a migraine attack that is already ongoing.